Léna Mazza
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria 2
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research 4
- SARS-CoV-2 detection and testing 4
- COVID-19 Clinical Research Studies 1
-
- Biosensors and Analytical Detection 3
-
- Health Policy Implementation Science 1
-
- Plant Pathogenic Bacteria Studies 1
-
- Bacterial Genetics and Biotechnology 1
- Co-authors
- L. MoyniéDirk BumannJames H. NaismithThilo KöhlerDaniel PletzerAlexandre LüscherLaurent KaiserThomas Agoritsas
- Journals
- Antimicrobial Agents and Chemotherapy (1 paper)Frontiers in Microbiology (1 paper)Clinical Microbiology and Infection (1 paper)
- Partner nations
- SwitzerlandUnited StatesItaly
In The Last Decade
Léna Mazza
5 papers receiving 258 citations
Peers
Comparison fields: 5 of 57
- Molecular Medicine 73
- Infectious Diseases 159
- Applied Microbiology and Biotechnology 15
- Pharmacology 33
- Endocrinology 9
Countries citing papers authored by Léna Mazza
This map shows the geographic impact of Léna Mazza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Léna Mazza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Léna Mazza more than expected).
Fields of papers citing papers by Léna Mazza
This network shows the impact of papers produced by Léna Mazza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Léna Mazza. The network helps show where Léna Mazza may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Léna Mazza, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2020 | 22 | |
| 4 | 2020 | 102 | |
| 5 | 2020 | 19 | |
| 6 | 2020 | 22 | |
| 7 | 2018 | 95 |
About Léna Mazza
Léna Mazza is a scholar working on Molecular Medicine, Infectious Diseases and Biomedical Engineering, having authored 7 papers that have together received 260 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (4 papers), SARS-CoV-2 detection and testing (4 papers), Biosensors and Analytical Detection (3 papers), Antibiotic Resistance in Bacteria (2 papers), Health Policy Implementation Science (1 paper), Plant Pathogenic Bacteria Studies (1 paper), COVID-19 Clinical Research Studies (1 paper) and Bacterial Genetics and Biotechnology (1 paper). The work is most often cited by research in Molecular Medicine (73 citations), Infectious Diseases (159 citations) and Applied Microbiology and Biotechnology (15 citations). Léna Mazza has collaborated with scholars based in Switzerland, United States and Italy. Frequent co-authors include L. Moynié, Dirk Bumann, James H. Naismith, Thilo Köhler, Daniel Pletzer, Alexandre Lüscher, Laurent Kaiser, Thomas Agoritsas, Giulia Torriani and Isabella Eckerle. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Frontiers in Microbiology and Clinical Microbiology and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.